news

Aug 26 2014
Synthetic Biologics Announces Presentation of Poster for SYN-004 C. difficile Program at IDWeek 2014

Aug 25 2014
Advaxis and Merck Form Collaboration to Evaluate Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer

Aug 21 2014
Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer

 

events

 

spotlight